Pyxis Oncology is trading 7.77% up at $3.05, with broader risk-on sentiment and positioning around an estimated earnings release potentially supporting the rebound.
- The August 11, 2026 close was $2.83, following a 26.11% decline.
- The Nasdaq was up 0.71%.
- No new company-specific announcement clearly explains the August 12 move; earnings timing remains unconfirmed.